A Randomized Factorial-Design Phase II Trial of Temozolomide in Combination with possible Permutations of Thalidomide Isotretinoin and/or Celecoxib as Post-Radiation Adjuvant of Glioblastoma Mutiforme

    Project: Non Profit

    Project Details

    StatusFinished
    Effective start/end date1/6/101/5/12

    Funding

    • Univ of Texas MD Anderson Cancer Center